Search
for
Sort by
Research 91–120 of 1000+
- Steroid Responsive Mononeuritis Multiplex in the Cronkhite–Canada Syndrome
- Investigation of Transcriptional Gene Profiling in Normal Murine Hair Follicular Substructures Using Next-Generation Sequencing to Provide Potential Insights into Skin Disease
- Advances in Innovative Surgical Implant Manufacturing for Hernia Repair and Soft Tissue Reconstruction
- Revolutionizing Radiotoxicity Management with Mesenchymal Stem Cells and Their Derivatives: A Focus on Radiation-Induced Cystitis
- Phytochemicals of Alpinia zerumbet: A Review
- Commensal microbiome promotes hair follicle regeneration by inducing keratinocyte HIF-1α signaling and glutamine metabolism
- Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring
- Repurposing Metformin for Dermatological Use: Mechanisms, Evidence, and Clinical Perspectives
- Resequencing Analyses Revealed Genetic Diversity and Selection Signatures during Rabbit Breeding and Improvement
- When one size does not fit all: Reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Maintenance of Hair Follicle Immune Privilege Is Linked to Prevention of NK Cell Attack
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- [Significance of HLA-DR+ T cells and natural killer (NK) cells in the peripheral blood lymphocytes of alopecia areata (AA)].
- Therapeutic effect of <i>Nepenthes kampotiana</i> Lecomte ethanol extract (Nk-EE) on androgenic alopecia through the inhibition of apoptosis and 5α-reductase activity
- Therapeutic Effect of <i>Nepenthes kampotiana</i> Lecomte Ethanol Extract (Nk-EE) on Androgenic Alopecia through the Inhibition of Apoptosis and 5a-Reductase Activity
- N,N-Dimethylglycine Sodium Salt Exerts Marked Anti-Inflammatory Effects in Various Dermatitis Models and Activates Human Epidermal Keratinocytes by Increasing Proliferation, Migration, and Growth Factor Release
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Hair follicle immune privilege and its collapse in alopecia areata
- Natural killer cells in atopic and autoimmune diseases of the skin
- Frontiers in alopecia areata pathobiology research
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Pathomechanisms of immune-mediated alopecia
- ALOPECIA UNIVERSALIS TREATED WITH ORAL CYCLOSPORINE A AND PREDNISOLONE: IMMUNOLOGIC STUDIES
- Treatment of alopecia areata: “What is new on the horizon?”
- The role of natural killer cells in autoimmune blistering diseases
- Functional interrogation of lymphocyte subsets in alopecia areata using single-cell RNA sequencing
- The Effect of Mushroom Beta‐Glucans from Solid Culture of <i>Ganoderma lucidum</i> on Inhibition of the Primary Tumor Metastasis
- RETRACTED: Causal role of immune cells in alopecia areata: A two‐sample Mendelian randomization study